Pharmacy
Providers focusing on access and treatment, payers looking at affordability, and innovators trying new therapies need to get together, says Micah Litow.
Though the vaccination rate is higher among older Americans, disparities emerge along racial and ethnic lines.
Available in early 2024, ClearNetwork will apply to all drugs on a plan sponsor's list of covered generic, branded and specialty medications.
Continuity of care is the top mentioned reason for health systems owning and operating ambulatory pharmacies.
Once the current strategy is implemented, 98% of all consumers will have access to insulin for $35 per month, company says.
The bill would introduce more transparency and regulation to PBMs, and pharmacies would be required to report costs for medications.
This could also improve outcomes for racial and ethnic minority groups, who generally have higher rates of hypertension.
Premier and the American Hospital Association laud a recent Supreme Court decision but say HHS is still acting unlawfully.
Nostrum admitted it acquired Nitro OS from another manufacturer and continued to market it based on its preexisting FDA approval.
Cloud platform JUDI drives savings for plan sponsors by providing patients with the lowest available drug prices, company says.